相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effects of resection margin and KRAS status on outcomes after resection of colorectal liver metastases
Ayiesha Ahmad Zalmani Hatta et al.
HPB (2021)
Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status
Diamantis Tsilimigras et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)
Hepatic metastasis from colorectal cancer
Alfred Wei Chieh Kow
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2019)
The Tumor Burden Score: A New Metro-ticket Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors
Kazunari Sasaki et al.
ANNALS OF SURGERY (2018)
Impact of Surgical Margin Width on Recurrence and Overall Survival Following R0 Hepatic Resection of Colorectal Metastases A Systematic Review and Meta-analysis
Georgios A. Margonis et al.
ANNALS OF SURGERY (2018)
Introduction: the rise of the robots in spinal surgery
Nicholas Theodore et al.
Neurosurgical Focus (2018)
Surgical Treatment of Metastatic Colorectal Cancer
Jeffery Chakedis et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2018)
Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer
Georgios Antonios Margonis et al.
JAMA SURGERY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The prognostic utility of the Tumor Burden Score based on preoperative radiographic features of colorectal liver metastases
Kazunari Sasaki et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Surgical management of colorectal cancer: the Fudan University Shanghai Cancer Center experience
Yuchen Wu et al.
TRANSLATIONAL CANCER RESEARCH (2017)
Anatomical Resections Improve Disease-free Survival in Patients With KRAS-mutated Colorectal Liver Metastases
Georgios A. Margonis et al.
ANNALS OF SURGERY (2017)
Effect of KRAS and BRAF Mutations on Survival of Metastatic Colorectal Cancer After Liver Resection: A Systematic Review and Meta-Analysis
Federica Tosi et al.
CLINICAL COLORECTAL CANCER (2017)
Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study
R. Dienstmann et al.
ANNALS OF ONCOLOGY (2017)
Colorectal cancer statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2016)
Phase II Trial of Hepatic Artery Infusional and Systemic Chemotherapy for Patients With Unresectable Hepatic Metastases From Colorectal Cancer Conversion to Resection and Long-term Outcomes
Michael I. D'Angelica et al.
ANNALS OF SURGERY (2015)
Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
Rene Adam et al.
CANCER TREATMENT REVIEWS (2015)
Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
Lydia G. M. van der Geest et al.
CLINICAL & EXPERIMENTAL METASTASIS (2015)
Metastatic Colorectal Cancer: Current State and Future Directions
Marwan G. Fakih
JOURNAL OF CLINICAL ONCOLOGY (2015)
Tumour biology of colorectal liver metastasis is a more important factor in survival than surgical margin clearance in the era of modern chemotherapy regimens
Stephanie Truant et al.
HPB (2015)
RAS Mutations Affect Pattern of Metastatic Spread and Increase Propensity for Brain Metastasis in Colorectal Cancer
Rona Yaeger et al.
CANCER (2015)
Updated guidelines for biomarker testing in colorectal carcinoma: a national consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
P. Garcia-Alfonso et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2015)
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
J. Y. Douillard et al.
ANNALS OF ONCOLOGY (2014)
Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients
Luca Vigano et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
KRAS Mutation Influences Recurrence Patterns in Patients Undergoing Hepatic Resection of Colorectal Metastases
Nancy E. Kemeny et al.
CANCER (2014)
Patterns of metachronous metastases after curative treatment of colorectal cancer
Yvette R. B. M. van Gestel et al.
CANCER EPIDEMIOLOGY (2014)
RAS testing of colorectal carcinoma-a guidance document from the Association of Clinical Pathologists Molecular Pathology and Diagnostics Group
Newton A. C. S. Wong et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial
John Primrose et al.
LANCET ONCOLOGY (2014)
RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
Jean-Nicolas Vauthey et al.
ANNALS OF SURGERY (2013)
The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review
A. A. P. Slesser et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
H. J. Schmoll et al.
ANNALS OF ONCOLOGY (2012)
Angiogenesis in Synchronous and Metachronous Colorectal Liver Metastases The Liver as a Permissive Soil
Gesiena E. van der Wal et al.
ANNALS OF SURGERY (2012)
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Luis A. Diaz et al.
NATURE (2012)
Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment
E. Van Cutsem et al.
ANNALS OF ONCOLOGY (2010)
KRAS Mutation Correlates With Accelerated Metastatic Progression in Patients With Colorectal Liver Metastases
Garrett M. Nash et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Improved Survival in Metastatic Colorectal Cancer Is Associated With Adoption of Hepatic Resection and Improved Chemotherapy
Scott Kopetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: A critical appraisal of the 1 cm rule
Z. Z. R. Hamady et al.
EJSO (2006)
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases
TM Pawlik et al.
ANNALS OF SURGERY (2005)
Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival
J Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer
S Miyagawa et al.
HUMAN PATHOLOGY (2004)
分享论文
